DEIDRE BROWN: Open Payments
NPI 1588110365 · ENGLEWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 48 payments from 12 companies in 2025. Trend: 2023 $193 · 2024 $243 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $297 |
| Alkermes, Inc. | 8 | $136 |
| ABBVIE INC. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| SCILEX PHARMACEUTICALS INC. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, COBENFY, REXULTI, LYBALVI, GVOKE HYPOPEN, MOUNJARO.
Industry payments across TN — which companies pay providers there.
